Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001522780-25-000008

Director sold 2,136 shares at an average $30.22 ($64,541)

  • Director acquired 4,317 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kaye Edward M. MD · Director

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-01 Exercise or conversion : show line 1 in the form +4,317 53,441 D
2025-12-02 Sale : show line 2 in the form −661 $29.56 $19,540 52,780 D
2025-12-02 Sale : show line 3 in the form −405 $30.14 $12,207 52,375 D
2025-12-03 Sale : show line 4 in the form −419 $30.34 $12,712 51,956 D
2025-12-03 Sale : show line 5 in the form −651 $30.85 $20,082 51,305 D
Open-market sales · 2,136 sh · avg $30.22 · $64,541

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-12-01 Exercise or conversion : show line 6 in the form Restricted Stock Units −4,317 0 D
Loading xslF345X05/form4-12042025_011205.xml…